Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired immunodeficiency syndrome-associated lymphomas.

C E Freter1

  • 1Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.

Journal of the National Cancer Institute. Monographs
|January 1, 1990
PubMed
Summary

Individuals with immunodeficiency, including those with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS), face a higher risk of developing non-Hodgkin's lymphomas. Treatment strategies are evolving, focusing on less intensive chemotherapy and prophylaxis for opportunistic infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.

Current medicinal chemistry·2012
Same author

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002
Same author

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Intravascular large cell lymphoma coexisting within hemangiomas of the skin.

The American journal of surgical pathology·1997
Same author

Hodgkin's disease treated with neck radiation is associated with increased antibody-dependent cellular cytotoxicity against human extraocular muscle cells.

Thyroid : official journal of the American Thyroid Association·1997
Same author

Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.

Leukemia & lymphoma·1996

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Immunodeficiency states, both congenital and acquired, are linked to an increased risk of malignant lymphoma.
  • Non-Hodgkin's lymphomas (NHL) were notably observed in patients with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS).

Purpose of the Study:

  • To explore the association between HIV infection and the development of lymphomas.
  • To understand the potential etiologic mechanisms and clinical presentation of HIV-associated lymphomas.
  • To review therapeutic approaches and prognostic factors for these lymphomas.

Main Methods:

  • Review of existing literature and clinical observations regarding HIV-associated lymphomas.
  • Analysis of potential pathogenetic links involving Epstein-Barr virus (EBV) and chromosomal translocations.

Related Experiment Videos

  • Evaluation of treatment outcomes and prognostic indicators in affected patients.

    • Main Results:

    • HIV-associated lymphomas often exhibit high-grade histopathology, advanced stage, and extranodal involvement, including the central nervous system.
    • Aggressive chemotherapy has shown suboptimal results; less myelosuppressive regimens with prophylaxis are now favored.
    • Prognostic factors are predominantly linked to HIV status, including CD4 count, performance status, and prior AIDS diagnosis.

    Conclusions:

    • HIV infection significantly increases the risk of specific types of lymphomas, potentially through immune dysregulation and viral co-infections.
    • Treatment requires tailored approaches considering the patient's overall health and HIV status.
    • CD4 lymphocyte count, performance status, and prior AIDS diagnosis are critical prognostic indicators.